3
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Amplification of MDM2 Inhibits MyoD-Mediated Myogenesis

, , &
Pages 5048-5057 | Received 20 Feb 1996, Accepted 22 May 1996, Published online: 29 Mar 2023

REFERENCES

  • Barr, F. G., N. Galili, J. Holick, J. A. Biegel, G. Rovera, and B. S. Emanuel. 1993. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3:113–117.
  • Budowle, B., and F. S. Baechtel. 1990. Modifications to improve the effectiveness of restriction fragment length polymorphism typing. Appl. Theor. Electrophor. 1:181–187.
  • Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107–4114.
  • Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991–1995.
  • Dias, P., D. M. Parham, D. N. Shapiro, B. L. Webber, and P. J. Houghton. 1990. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am. J. Pathol. 137:1283–1291.
  • Falcone, G., F. Tato, and S. Alema. 1985. Distinctive effects of the viral oncogenes myc, erb, fps, and src on the differentiation program of quail myogenic cells. Proc. Natl. Acad. Sci. USA 82:426–430.
  • Favaloro, J., R. Freisman, and R. Kamen. 1980. Transcription maps of polyoma virus-specific RNA: analysis by two dimensional nuclease S1 gel mapping. Methods Enzymol. 65:718–749.
  • Fiddler, T., and M. Thayer. Unpublished observations.
  • Fiszman, M. Y., and P. Fuchs. 1975. Temperature-sensitive expression of differentiation in transformed myoblasts. Nature (London) 254:429–431.
  • Fournier, R. E. K. 1981. A general high-efficiency procedure for production of microcell hybrids. Proc. Natl. Acad. Sci. USA 78:6349–6353.
  • Garson, J. A., J. Clayton, P. McIntyre, and J. T. Kemshead. 1986. N-myc oncogene amplification in rhabdomyosarcoma at release. Lancet i:1496. (Letter.)
  • Garvin, A. J., W. S. Stanley, D. D. Bennett, J. L. Sullivan, and D. A. Sens. 1986. The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. Am. J. Pathol. 125:208–217.
  • Gossett, L. A., W. Zhang, and E. N. Olson. 1988. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes. J. Cell Biol. 106:2127–2137.
  • Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309–324.
  • Haines, D. S., J. E. Landers, L. J. Engle, and D. L. George. 1994. Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14:1171–1178.
  • Hazelton, B. J., J. A. Houghton, D. M. Parham, E. C. Douglass, P. M. Torrance, H. Holt, and P. J. Houghton. 1987. Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res. 47:4501–4507.
  • Holtzer, H., J. Biehl, G. Yeoh, R. Meganathan, and A. Kaji. 1975. Effect of oncogenic virus on muscle differentiation. Proc. Natl. Acad. Sci. USA 72:4051–4055.
  • Houghton, P. Personal communication.
  • Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
  • Khatib, Z. A., H. Matsushime, M. Valentine, D. N. Shapiro, C. J. Sherr, and A. T. Look. 1993. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 53:5535–5541.
  • Kinzler, K. W., S. H. Bigner, D. D. Bigner, J. M. Trent, M. L. Law, S. J. O’Brien, A. J. Wong, and B. Vogelstein. 1987. Identification of an amplified, highly expressed gene in a human glioma. Science 236:70–73.
  • Lassar, A. B., S. X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788–794.
  • Lassar, A. B., M. J. Thayer, R. W. Overell, and H. Weintraub. 1989. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58:659–667.
  • Ludecke, H.-J., G. Senger, U. Claussen, and B. Horsthemke. 1989. Cloning defined regions of the human genome by microdissection of banded chromosomes and enzymatic amplification. Nature (London) 338:348–350.
  • Lugor, T. G., B. Handelin, A. M. Killary, D. E. Housman, and R. E. Fournier. 1987. Isolation of microcell hybrid clones containing retroviral insertions into specific human chromosomes. Mol. Cell. Biol. 7:2814–2820.
  • Martin, K., D. Trouche, C. Hagemeier, T. S. Sorensen, N. B. La-Thangue, and T. Kouzarides. 1995. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature (London) 375:691–694.
  • Mitani, K., H. Kurosawa, A. Suzuki, Y. Hayashi, R. Hanada, K. Yamamoto, A. Komatsu, N. Kobayashi, Y. Nakagome, and M. Yamada. 1986. Amplification of N-myc in a rhabdomyosarcoma. Jpn. J. Cancer Res. 77:1062–1065.
  • Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245.
  • Nelson, D. L., A. Ballabio, M. F. Victoria, M. Pieretti, R. D. Bies, R. A. Gibbs, J. A. Maley, A. C. Chinault, T. D. Webster, and C. T. Caskey. 1991. Alu-primed polymerase chain reaction for regional assignment of 110 yeast artificial chromosome clones from the human X chromosome: identification of clones associated with a disease locus. Proc. Natl. Acad. Sci. USA 88:6157–6161.
  • Nelson, D. L., S. A. Ledbetter, L. Corbo, M. F. Victoria, S. R. Ramirez, T. D. Webster, D. H. Ledbetter, and C. T. Caskey. 1989. Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc. Natl. Acad. Sci. USA 86:6686–6690.
  • Newsham, I., U. Claussen, H. J. Ludecke, M. Mason, G. Senger, B. Horsthemke, and W. Cavenee. 1991. Microdissection of chromosome band 11p15.5: characterization of probes mapping distal to the HBBC locus. Genes Chromosome Cancer. 3:108–116.
  • Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (London) 358:80–83.
  • Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (London) 362:857–860.
  • Olson, E. N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol. 154:261–272.
  • Olson, E. N., G. Spizz, and M. A. Tainsky. 1987. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell. Biol. 7:2104–2111.
  • Payne, P. A., E. N. Olson, P. Hsiau, R. Roberts, M. B. Perryman, and M. D. Schneider. 1987. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Proc. Natl. Acad. Sci. USA 84:8956–8960.
  • Peterson, C. A., H. Gordon, Z. W. Hall, B. M. Paterson, and H. M. Blau. 1990. Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant. Cell 62:493–502.
  • Rao, S. S., C. Chu, and S. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259–5267.
  • Reifenberger, G., J. Reifenberger, K. Ichimura, P. S. Meltzer, and V. P. Collins. 1994. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the ampli-cons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res. 54:4299–4303.
  • Roberts, W. M., E. C. Douglass, S. C. Peiper, P. J. Houghton, and A. T. Look. 1989. Amplification of the gli gene in childhood sarcomas. Cancer Res. 49:5407–5413.
  • Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb−/− muscle cells. Science 264:1467–1471.
  • Schneider, M. D., M. B. Perryman, P. A. Payne, G. Spizz, R. Roberts, and E. N. Olson. 1987. Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation. Mol. Cell. Biol. 7:1973–1977.
  • Scrable, H. J., D. K. Johnson, E. M. Rinchik, and W. K. Cavenee. 1990. Rhabdomyosarcoma-associated locus and MYOD1 are syntenic but separate loci on the short arm of human chromosome 11. Proc. Natl. Acad. Sci. USA 87:2182–2186.
  • Seed, B., and J.-Y. Sheen. 1988. A simple phase-extraction assay for chloramphenicol acetyltransferase activity. Gene 67:271–277.
  • Shapiro, D. N., J. E. Sublett, B. Li, J. R. Downing, and C. W. Naeve. 1993. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer. Res. 53:5108–5112.
  • Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022–1024.
  • Smith, L., and M. Thayer. Unpublished observations.
  • Stark, G. R., M. Debatisse, E. Giulotto, and G. M. Wahl. 1989. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57:901–908.
  • Tapscott, S., and M. Thayer. Unpublished observations.
  • Tapscott, S. J., M. J. Thayer, and H. Weintraub. 1993. Deficiency in rhab-domyosarcomas of a factor required for MyoD activity and myogenesis. Science 259:1450–1453.
  • Thayer, M. Unpublished observations.
  • Thulin, J., and M. Thayer. Unpublished observations.
  • Tlsty, T. D. 1990. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. USA 87:3132–3136.
  • Trask, B., and D. Pinkel. 1990. Flow cytometry. Academic Press, New York.
  • Webster, K. A., G. E. Muscat, and L. Kedes. 1988. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (London) 332:553–557.
  • Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126–1132.
  • Xiao, Z. X., J. Chen, A. J. Levine, N. Modjtahedi, J. Xing, W. R. Sellers, and D. M. Livingston. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (London) 375:694–698.
  • Yunis, J. J., and M. E. Chandler. 1978. High-resolution chromosome analysis in clinical medicine. Prog. Clin. Pathol. 7:267–288.
  • Zauberman, A., Y. Barak, N. Ragimov, N. Levy, and M. Oren. 1993. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J. 12:2799–2808.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.